BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 36674804)

  • 1. Identification of Side Chain Oxidized Sterols as Novel Liver X Receptor Agonists with Therapeutic Potential in the Treatment of Cardiovascular and Neurodegenerative Diseases.
    Zhan N; Wang B; Martens N; Liu Y; Zhao S; Voortman G; van Rooij J; Leijten F; Vanmierlo T; Kuipers F; Jonker JW; Bloks VW; Lütjohann D; Palumbo M; Zimetti F; Adorni MP; Liu H; Mulder MT
    Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674804
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of Liver X Receptors and Peroxisome Proliferator-Activated Receptors by Lipid Extracts of Brown Seaweeds: A Potential Application in Alzheimer's Disease?
    Martens N; Zhan N; Voortman G; Leijten FPJ; van Rheenen C; van Leerdam S; Geng X; Huybrechts M; Liu H; Jonker JW; Kuipers F; Lütjohann D; Vanmierlo T; Mulder MT
    Nutrients; 2023 Jun; 15(13):. PubMed ID: 37447330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sterol intermediates from cholesterol biosynthetic pathway as liver X receptor ligands.
    Yang C; McDonald JG; Patel A; Zhang Y; Umetani M; Xu F; Westover EJ; Covey DF; Mangelsdorf DJ; Cohen JC; Hobbs HH
    J Biol Chem; 2006 Sep; 281(38):27816-26. PubMed ID: 16857673
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of intestinal ATP-binding cassette transporters by a phytosterol-derived liver X receptor agonist.
    Kaneko E; Matsuda M; Yamada Y; Tachibana Y; Shimomura I; Makishima M
    J Biol Chem; 2003 Sep; 278(38):36091-8. PubMed ID: 12847102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 24(S)-Saringosterol from edible marine seaweed Sargassum fusiforme is a novel selective LXRβ agonist.
    Chen Z; Liu J; Fu Z; Ye C; Zhang R; Song Y; Zhang Y; Li H; Ying H; Liu H
    J Agric Food Chem; 2014 Jul; 62(26):6130-7. PubMed ID: 24927286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adaptive responses induced by 24S-hydroxycholesterol through liver X receptor pathway reduce 7-ketocholesterol-caused neuronal cell death.
    Okabe A; Urano Y; Itoh S; Suda N; Kotani R; Nishimura Y; Saito Y; Noguchi N
    Redox Biol; 2013; 2():28-35. PubMed ID: 24371802
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 24(S)-hydroxycholesterol participates in a liver X receptor-controlled pathway in astrocytes that regulates apolipoprotein E-mediated cholesterol efflux.
    Abildayeva K; Jansen PJ; Hirsch-Reinshagen V; Bloks VW; Bakker AH; Ramaekers FC; de Vente J; Groen AK; Wellington CL; Kuipers F; Mulder M
    J Biol Chem; 2006 May; 281(18):12799-808. PubMed ID: 16524875
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liver X receptors (LXRs). Part I: structure, function, regulation of activity, and role in lipid metabolism.
    Wójcicka G; Jamroz-Wiśniewska A; Horoszewicz K; Bełtowski J
    Postepy Hig Med Dosw (Online); 2007 Dec; 61():736-59. PubMed ID: 18063918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Desmosterol can replace cholesterol in sustaining cell proliferation and regulating the SREBP pathway in a sterol-Delta24-reductase-deficient cell line.
    Rodríguez-Acebes S; de la Cueva P; Fernández-Hernando C; Ferruelo AJ; Lasunción MA; Rawson RB; Martínez-Botas J; Gómez-Coronado D
    Biochem J; 2009 May; 420(2):305-15. PubMed ID: 19260826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fucosterol is a selective liver X receptor modulator that regulates the expression of key genes in cholesterol homeostasis in macrophages, hepatocytes, and intestinal cells.
    Hoang MH; Jia Y; Jun HJ; Lee JH; Lee BY; Lee SJ
    J Agric Food Chem; 2012 Nov; 60(46):11567-75. PubMed ID: 23116181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LXR agonists: new potential therapeutic drug for neurodegenerative diseases.
    Xu P; Li D; Tang X; Bao X; Huang J; Tang Y; Yang Y; Xu H; Fan X
    Mol Neurobiol; 2013 Dec; 48(3):715-28. PubMed ID: 23625315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LXR-activating oxysterols induce the expression of inflammatory markers in endothelial cells through LXR-independent mechanisms.
    Morello F; Saglio E; Noghero A; Schiavone D; Williams TA; Verhovez A; Bussolino F; Veglio F; Mulatero P
    Atherosclerosis; 2009 Nov; 207(1):38-44. PubMed ID: 19426978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulatory effects of synthetic liver X receptor- and peroxisome-proliferator activated receptor agonists on sterol transport pathways in polarized cerebrovascular endothelial cells.
    Panzenboeck U; Kratzer I; Sovic A; Wintersperger A; Bernhart E; Hammer A; Malle E; Sattler W
    Int J Biochem Cell Biol; 2006; 38(8):1314-29. PubMed ID: 16530456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 27-hydroxycholesterol is an endogenous ligand for liver X receptor in cholesterol-loaded cells.
    Fu X; Menke JG; Chen Y; Zhou G; MacNaul KL; Wright SD; Sparrow CP; Lund EG
    J Biol Chem; 2001 Oct; 276(42):38378-87. PubMed ID: 11504730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 7-Dehydrocholesterol metabolites produced by sterol 27-hydroxylase (CYP27A1) modulate liver X receptor activity.
    Endo-Umeda K; Yasuda K; Sugita K; Honda A; Ohta M; Ishikawa M; Hashimoto Y; Sakaki T; Makishima M
    J Steroid Biochem Mol Biol; 2014 Mar; 140():7-16. PubMed ID: 24269243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Knock-down of the oxysterol receptor LXRα impairs cholesterol efflux in human primary macrophages: lack of compensation by LXRβ activation.
    Ishibashi M; Filomenko R; Rébé C; Chevriaux A; Varin A; Derangère V; Bessède G; Gambert P; Lagrost L; Masson D
    Biochem Pharmacol; 2013 Jul; 86(1):122-9. PubMed ID: 23313547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of ABCG4 transporter expression by sterols and LXR ligands.
    Yang A; Alrosan AZ; Sharpe LJ; Brown AJ; Callaghan R; Gelissen IC
    Biochim Biophys Acta Gen Subj; 2021 Jan; 1865(1):129769. PubMed ID: 33141061
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interplay between LXR and Wnt/β-catenin signaling in the negative regulation of peripheral myelin genes by oxysterols.
    Makoukji J; Shackleford G; Meffre D; Grenier J; Liere P; Lobaccaro JM; Schumacher M; Massaad C
    J Neurosci; 2011 Jun; 31(26):9620-9. PubMed ID: 21715627
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery and implementation of transcriptional biomarkers of synthetic LXR agonists in peripheral blood cells.
    DiBlasio-Smith EA; Arai M; Quinet EM; Evans MJ; Kornaga T; Basso MD; Chen L; Feingold I; Halpern AR; Liu QY; Nambi P; Savio D; Wang S; Mounts WM; Isler JA; Slager AM; Burczynski ME; Dorner AJ; LaVallie ER
    J Transl Med; 2008 Oct; 6():59. PubMed ID: 18925943
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phytosterols Inhibit Side-Chain Oxysterol Mediated Activation of LXR in Breast Cancer Cells.
    Hutchinson SA; Lianto P; Moore JB; Hughes TA; Thorne JL
    Int J Mol Sci; 2019 Jul; 20(13):. PubMed ID: 31269628
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.